Wednesday, October 4, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from Karuna Therapeutics
Steering Committee Chair
Professor of Psychiatry and Molecular Medicine
Zucker School of Medicine at Hofstra/Northwell
New York, New York, United States
Professor of Child and Adolescent Psychiatry
Charité University Medicine
Berlin, Germany
Steering Committee Member
Professor of Psychiatry
Indiana University School of Medicine
Indianapolis, Indiana, United States
Steering Committee Member
Clinical Professor of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York, United States
Steering Committee Member
MPower Professor of Psychiatry
State of Maryland Strategic Partnership: MPowering the State
Acting Director, Maryland Psychiatric Research Center
University of Maryland School of Medicine
Baltimore, Maryland
Steering Committee Member
Professor of Psychiatry and Behavioral Sciences, Pharmacology and Neuroscience
Director of the Translational Neuropharmacology Program
Northwestern University
Chicago, Illinois
Steering Committee Member
Voluntary Clinical Professor of Psychiatry
University of California, San Diego
San Diego, California
Steering Committee Chair
Has the following relevant financial relationships:
Consultant or advisor for: AbbVie; Acadia; Alkermes; Allergan; Angelini; Aristo; Axsome; Boehringer-Ingelheim; Cardio Diagnostics; Cerevel; Compass Pathways; CNX Therapeutics; Damitsa; Gedeon Richter; Hikma; Holmusk; Intra-Cellular Therapies; Janssen/J&J; Karuna; LB Pharma; Lundbeck; MedAvante-ProPhase; MedinCell; Medscape; Merck; MindPax; Mitsubishi Tanabe Pharma; Mylan; Neurocrine; Newron; Noven; Otsuka; Pfizer; Pharmabrain; PPD Biotech; Recordati; Relmada; Reviva; ROVI; Seqirus; Servier; SK Life Science; Sumitomo Dainippon; Sun Pharma; Sunovion; Supernus; Takeda; Teva; Viatris
Speaker or member of speakers bureau for: AbbVie; Angelini; Aristo; Damitsa; Gedeon Richter; Hikma; Intra-Cellular Therapies; Janssen/J&J; Lundbeck; Mitsubishi Tanabe Pharma; Mylan; Otsuka; Recordati; Seqirus; Sunovion; Takeda, Viatris
Research funding from: Janssen; Takeda
Stock options from: Cardio Diagnostics; MindPax; LB Pharma; Quantic
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: Arrivo Sirtsei; BioXcel Therapeutics; Karuna Therapeutics; Perception Neuroscience;
Stock options from: Karuna Therapeutics; Perception Neuroscience
Owns stock (publicly traded) in: Karuna Therapeutics
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AbbVie/Allergan; Acadia; Adamas; Alkermes; Angelini; Astellas; Avanir; Axsome; BioXcel; Boehringer Ingelheim; Cadent Therapeutics; Cerevel; Clinilabs; COMPASS; Eisai; Enteris BioPharma; HLS Therapeutics; Idorsia; INmune Bio; Impel; Intra-Cellular Therapies; Janssen; Karuna; Lundbeck; Lyndra; Medavante-ProPhase; Marvin; Merck; Mitsubishi Tanabe Pharma; Neurocrine; Neurelis; Novartis; Noven; Otsuka; Ovid; Praxis; Recordati; Relmada; Reviva; Sage; Sunovion; Supernus; Teva
Speaker or member of speakers bureau for: AbbVie/Allergan; Acadia; Alkermes; Angelini; Axsome; BioXcel; Eisai; Idorsia; Intra-Cellular Therapies; Janssen; Lundbeck; Neurocrine; Noven; Otsuka; Recordati; Sage; Sunovion; Takeda; Teva
Stock options from: Reviva
Owns stock (publicly traded) in: Bristol Myers Squibb; Eli Lilly; J&J; Merck; Pfizer
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: Alkermes, Inc; Janssen; Sunovion Pharmaceuticals Inc.
Research funding from: Saladax Biomedical Inc.
Steering Committee Member
Has no relevant financial relationships.
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: Alkermes; Cerevel; Intra-Cellular Therapies; Karuna; Neurocrine; Otsuka America, Inc.; Relmada; Sunovion; Teva
Speaker or member of speakers bureau for: Alkermes; Intra-Cellular Therapies; Janssen; Neurocrine; Noven; Sunovion; Teva
